Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Users Online: 227
Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Login 
     

    Article Cited by others

SYMPOSIUM

Toxoplasmosis in organ transplant recipients: Evaluation, implication, and prevention

Khurana Sumeeta, Batra Nitya

Year : 2016| Volume: 6| Issue : 2 | Page no: 123-128

   This article has been cited by
 
1 In deep: cerebral toxoplasmosisRunning Head: Cerebral Toxoplasmosis in Immunocompromised Host
Melanie R.F. Greenway,Keith A. Sacco,M. Caroline Burton
The American Journal of Medicine. 2017;
[Pubmed]  [Google Scholar] [DOI]
2 Mast cell activator compound 48/40 is not an effective adjuvant for UV-attenuated Toxoplasma gondii vaccine
Xi Li,Shengjie Chen,Shiguang Huang,Fangli Lu
Parasitology Research. 2017;
[Pubmed]  [Google Scholar] [DOI]

 

Read this article